Overweight NVDA with disciplined scale-in execution architecture
Overweight justified by Q2 FY27 print with $235B buyback creating asymmetric upside (106% YoY revenue growth, 75% gross margin), forward P/E 14.6x with PEG 0.47 materially mispriced if growth persists, and macro overlays bleeding alpha four consecutive times against intact structural bid. Bear case bounded by working capital risk (AR +127% YoY vs revenue +106% YoY requiring Q3 confirmation), $232 ceiling rejecting twice, MACD momentum fading (peak +2.28 now +0.37 unconfirmed), and suspicious $25B debt raise for buybacks at cycle peak. Position capped at 2% with hard stop at $204-205 daily close (vs $197 lower Bollinger) to avoid noise-out on beta-2.22 name with 5.86 ATR; hard invalidation at $197 triggers thesis review toward Underweight, not automatic Sell.
| Position | Action |
|---|---|
| Initial position at current $215-220 zone | 1.5% of portfolio |
| Second tranche at $208-212 on confirmed two-close hold with rising MACD histogram AND volume ≥100M shares | +0.5% of portfolio (total max 2%) |
| Price above $228 (failed-ceiling supply zone) | DO NOT add |
| Trim at $230-236 on declining volume + MACD divergence + distribution signature | Trim 20-25% of position |
| Volume >200M on push to $230-236 (breakout confirmation) | Defer trim |
| Hard cap at 2% of portfolio until $232 breakout confirms | Do not exceed upper bound until breakout |
NVDA's accelerating revenue growth (106% YoY), expanding 75% gross margins, and historic $235B buyback authorization create an asymmetric reward-risk profile with a forward PE of 14.6× and PEG of 0.47, positioning the stock for a textbook melt-up scenario even amid macro headwinds.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 199.13 | bullish |
| close_50_sma | 215.79 | bullish |
| close_10_ema | 223.23 | bullish |
| macd | 2.34 | bullish |
| macdh | 0.37 | bullish |
| rsi | 55.30 | neutral |
| boll_ub | 232.80 | neutral |
| boll_lb | 210.51 | neutral |
| vwma | 221.05 | bullish |
Support: 232.8 · 230.1 · 228.87 | Resistance: 223.23 · 221.05 · 215.79 · 210.51 · 199.13
NVDA maintains a firmly bullish multi-timeframe structure at 225.07, with price above the 200 SMA (199.13) by 13.0%, above the 50 SMA (215.79) by 4.3%, and just above the 10 EMA (223.23). A fresh MACD bullish crossover (line at 2.34, histogram at +0.37) and neutral RSI at 55.30 provide momentum confirmation with room for further upside before overbought conditions. Key resistance sits at 232.80 (upper Bollinger), while support zones are identified at 223.23 (10 EMA), 221.05 (VWMA), 215.79 (50 SMA), 210.51 (lower Bollinger), and 199.13 (200 SMA). Volume confirmation is healthy with VWMA rising and 190M shares traded on Sep 18, supporting the bullish bias as a continuation pattern rather than a blowoff top.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: 1.5% position inititation
↩ rebuts: “Bear's macro deterioration argument”
EV: ~$500 (~120% upside from $225, based on FY28 EPS $20+ at 25× forward multiple) · concedes: Retail traders are buying at peaks and getting burned in the short term; Some momentum compression occurred from August peak (MACD histogram +2.28 → Sep 16 low of -1.57); Macro headwinds are real: 97% probability of no Fed rate cuts in 2026, rising yields, geopolitical tension; Beta of 2.22 means NVDA will catch downdrafts in broad selloffs; Near-term downside scenario of $150-180 (~20-35% downside) is plausible if multiple negative catalysts converge
Narrative is not valuation, and a buyback announcement is not a floor. Every bullish signal presented—record buyback, peak sentiment, CEO defending valuation, technical resistance—is a late-cycle warning dressed up as a catalyst.
EV: $216 (-4%) if FY28 EPS lands at $12 with 18× multiple; $180 (-20%) if multiple compresses to 15×; $150-160 (-30%) if growth disappoints AND multiple compresses · concedes: NVDA is a high-quality business; CUDA is a real moat, though eroding; The $96B quarterly revenue is impressive in absolute terms
→ vs conservative: P/B of 24.13 times argument is applying a value-investing framework from 1965 to a 2026 AI infrastructure monopolist; companies with 117 percent ROE are valued on cash flow generation not book value
→ vs conservative: Working capital deterioration argument treats the operational signature of hypergrowth as a red flag; inventory build is WIP for Blackwell chips with orders already booked, not finished goods at risk of markdown
→ vs conservative: AMD 8.2 billion acquisition in stock to buy AI capability rather than build it organically is the most bullish competitive signal for NVIDIA's CUDA moat
→ vs conservative: Conservative position is essentially saying the setup is too good so something bad must happen, which is narrative bias not analysis
→ vs neutral: Waiting for 232 breakout means paying 228 to 232 and giving up 7 to 13 percent of upside from current levels with no incremental information
→ vs neutral: Buying breakouts instead of buying strength at support is the most expensive mistake in technical analysis; institutions are accumulating at 50 SMA, not chasing 232
→ vs neutral: Risk-reward of buying at 215 with 197 stop versus chasing 232 is dramatically different and waiting for confirmation is how you underperform benchmarks
Market Cap
$5.53T
P/E (TTM)
28.97×
Forward P/E
14.59×
P/B
24.13×
PEG Ratio
0.47
EV/EBITDA (TTM)
~26.5×
Revenue (TTM)
$302.97B
Gross Profit (TTM)
$226.24B
EBITDA (TTM)
$201.27B
Net Income (TTM)
$192.88B
Gross Margin (TTM)
74.7%
Operating Margin (TTM)
66.2%
Net Margin (TTM)
63.7%
ROE (TTM)
117.2%
ROA (TTM)
53.6%
EPS (TTM)
$7.90
Forward EPS
$15.68
FY2023 Revenue
$26.97B
FY2024 Revenue
$60.92B
FY2025 Revenue
$130.50B
FY2026 Revenue
$215.94B
FY2023 Net Income
$4.37B
FY2024 Net Income
$29.76B
FY2025 Net Income
$72.88B
FY2026 Net Income
$120.07B
FY2023 Diluted EPS
$0.17
FY2024 Diluted EPS
$1.19
FY2025 Diluted EPS
$2.94
FY2026 Diluted EPS
$4.90
Q2 FY27 Revenue
$96.22B
Q2 FY27 Gross Profit
$72.14B
Q2 FY27 Gross Margin
75.0%
Q2 FY27 Operating Income
$63.73B
Q2 FY27 Operating Margin
66.2%
Q2 FY27 Net Income
$59.69B
Q2 FY27 Diluted EPS
$2.46
Q1 FY27 Revenue
$81.62B
Q4 FY26 Revenue
$68.13B
Q3 FY26 Revenue
$57.01B
Q2 FY26 Revenue
$46.74B
Cash & Equivalents
$22.44B
Short-Term Investments
$40.03B
Total Liquid Securities
~$62.5B
Total Assets
$320.27B
Total Liabilities
$91.29B
Stockholders' Equity
$228.98B
Long-Term Debt
$32.37B
Net Debt
$10.92B
Debt-to-Equity
16.97
Current Ratio
4.59
Inventory
$31.58B
Work-in-Process Inventory
$13.38B
Finished Goods Inventory
$6.86B
Receivables
$63.06B
Goodwill
$21.13B
Available-For-Sale Securities
$51.16B
Book Value/Share
$9.48
FY26 Operating Cash Flow
$102.72B
FY26 Free Cash Flow
$96.68B
FY26 CapEx
$6.04B
FY26 Share Repurchases
$40.09B
FY26 Dividends Paid
$0.97B
TTM Free Cash Flow
$41.81B
TTM Operating Cash Flow
~$134B
Diluted Share Count (FY23)
25.07B
Diluted Share Count (FY26)
24.51B
Diluted Share Count (Q2 FY27)
~24.29B
52-Week High
$236.54
52-Week Low
$164.27
50-Day Average
$215.98
200-Day Average
$199.47
Beta
2.217
Dividend Yield
0.44%
Strengths
Concerns
NVIDIA's Q2 FY27 results confirm extraordinary operational momentum with $96.22B in revenue (+106% YoY) and 75.0% gross margins, driven by insatiable AI compute demand for Blackwell GPUs; TTM revenue stands at $302.97B with FY26 annual revenue of $215.94B (+65% YoY) and FY27 EPS projected at $15.68. The fortress balance sheet holds ~$62.5B in liquid assets against only $10.92B net debt, while elite capital allocation (117.2% ROE, $40B buybacks in FY26, declining share count) continues to compound per-share metrics — though the forward P/E of 14.6× and high beta of 2.22 suggest the stock is priced for flawless execution with limited margin for error given AI capex cycle risks, export controls, and custom silicon competition.
Macro: Macro backdrop is risk-off with 97% implied probability of NO Fed rate cuts in 2026 (Polymarket, volume $8.6M, +1pp WoW), relentless Treasury yield rise described as 'relentless' by analysts, and geopolitical escalation (Trump rejected Iran's nuclear proposal) triggering broad equity selling. Mark Zandi (Moody's) warned that higher rates are already damaging the economy. Bond-equity correlation is back in a 'yields down = stocks up' regime. The SPX/Dow/Nasdaq all closed lower under pressure from rising yields and geopolitical tension even as NVDA outperformed with a ~2.7% intraday pop on buyback news.